Your browser is no longer supported. Please, upgrade your browser.
GBT Global Blood Therapeutics, Inc. daily Stock Chart
GBT [NASD]
Global Blood Therapeutics, Inc.
Index- P/E- EPS (ttm)-4.88 Insider Own2.30% Shs Outstand60.79M Perf Week4.85%
Market Cap4.50B Forward P/E- EPS next Y-2.60 Insider Trans-13.93% Shs Float53.48M Perf Month6.85%
Income-290.90M PEG- EPS next Q-1.16 Inst Own- Short Float19.00% Perf Quarter8.90%
Sales16.20M P/S277.81 EPS this Y-34.30% Inst Trans9.55% Short Ratio10.71 Perf Half Y-15.14%
Book/sh8.61 P/B8.26 EPS next Y42.40% ROA-38.40% Target Price108.25 Perf Year26.95%
Cash/sh8.39 P/C8.48 EPS next 5Y37.00% ROE-47.20% 52W Range39.95 - 87.54 Perf YTD-10.53%
Dividend- P/FCF- EPS past 5Y-33.20% ROI-43.10% 52W High-18.76% Beta1.88
Dividend %- Quick Ratio8.80 Sales past 5Y- Gross Margin98.90% 52W Low78.02% ATR3.59
Employees352 Current Ratio9.10 Sales Q/Q- Oper. Margin- RSI (14)56.99 Volatility3.76% 5.51%
OptionableYes Debt/Eq0.14 EPS Q/Q-38.10% Profit Margin- Rel Volume0.81 Prev Close69.34
ShortableYes LT Debt/Eq0.14 EarningsMay 06 AMC Payout- Avg Volume948.63K Price71.12
Recom1.80 SMA207.63% SMA502.46% SMA2009.96% Volume764,025 Change2.57%
Jul-01-20Upgrade Goldman Neutral → Buy $91 → $103
Apr-28-20Initiated Stifel Buy $112
Jan-31-20Downgrade SunTrust Buy → Hold $110 → $75
Nov-25-19Resumed Cantor Fitzgerald Overweight $110 → $98
Nov-06-19Initiated Canaccord Genuity Hold $50
May-29-19Resumed Goldman Neutral
Dec-03-18Reiterated H.C. Wainwright Buy $125 → $150
Aug-06-18Initiated Piper Jaffray Overweight $80
Jun-27-18Reiterated H.C. Wainwright Buy $73 → $125
Jun-27-18Reiterated Cantor Fitzgerald Overweight $69 → $96
May-08-18Reiterated SunTrust Buy $80 → $77
Mar-21-18Downgrade Morgan Stanley Overweight → Equal-Weight
Feb-28-18Reiterated Cantor Fitzgerald Overweight $61 → $72
Feb-14-18Initiated Janney Buy
Jan-23-18Initiated William Blair Outperform
Dec-14-17Reiterated Needham Buy $51 → $70
Dec-01-17Initiated H.C. Wainwright Buy $73
Sep-21-17Initiated Needham Buy $51
Aug-08-17Reiterated JP Morgan Overweight $44 → $46
Apr-18-17Initiated SunTrust Buy $56
Jul-08-20 08:00AM  
Jun-25-20 01:00PM  
08:59AM  
Jun-24-20 08:30AM  
Jun-19-20 01:18AM  
Jun-18-20 04:05PM  
09:48AM  
Jun-12-20 06:37PM  
Jun-09-20 10:13AM  
02:08AM  
Jun-08-20 04:05PM  
Jun-05-20 11:31AM  
Jun-03-20 08:00AM  
Jun-02-20 10:21PM  
08:00AM  
May-29-20 06:45AM  
May-24-20 12:25PM  
May-15-20 10:58AM  
May-14-20 09:05AM  
May-07-20 08:00AM  
05:48AM  
May-06-20 05:35PM  
04:05PM  
May-05-20 08:45AM  
May-04-20 09:10AM  
08:55AM  
Apr-29-20 08:00AM  
07:00AM  
Apr-05-20 09:02PM  
Apr-03-20 08:00AM  
Apr-02-20 01:00PM  
Mar-27-20 11:31AM  
Mar-18-20 05:21PM  
06:40AM  
Mar-17-20 08:00AM  
Mar-04-20 02:13PM  
08:00AM  
Feb-29-20 08:25AM  
Feb-27-20 09:10AM  
Feb-26-20 06:05PM  
04:05PM  
Feb-25-20 08:00AM  
Feb-20-20 08:00AM  
Feb-19-20 08:00AM  
Feb-10-20 05:53PM  
Feb-03-20 08:00AM  
Jan-26-20 08:30AM  
Jan-13-20 05:29PM  
Jan-08-20 08:00AM  
Jan-07-20 08:00AM  
Jan-03-20 05:43PM  
Jan-02-20 04:42PM  
Dec-24-19 12:15PM  
Dec-23-19 08:05AM  
Dec-19-19 05:51PM  
05:20PM  
10:29AM  
Dec-18-19 07:51AM  
07:15AM  
07:00AM  
Dec-14-19 04:47PM  
Dec-10-19 04:31PM  
Dec-07-19 11:31AM  
Dec-06-19 10:03AM  
Dec-04-19 08:00AM  
Dec-02-19 10:17AM  
Nov-29-19 12:15PM  
11:30AM  
11:24AM  
09:26AM  
Nov-27-19 05:33PM  
10:09AM  
07:26AM  
03:28AM  
Nov-26-19 07:06PM  
04:15PM  
08:53AM  
08:06AM  
08:00AM  
Nov-25-19 04:49PM  
04:03PM  
03:56PM  
03:32PM  
Nov-18-19 04:43PM  
09:36AM  
Nov-08-19 10:00AM  
Nov-07-19 04:05PM  
Nov-06-19 09:00AM  
Nov-04-19 08:00AM  
Oct-24-19 02:15PM  
Oct-21-19 08:00AM  
Oct-18-19 10:23AM  
Oct-07-19 08:00AM  
Oct-02-19 08:00AM  
Oct-01-19 08:00AM  
Sep-25-19 08:00AM  
Sep-19-19 12:48PM  
Sep-11-19 10:23AM  
Sep-06-19 11:53AM  
09:31AM  
Global Blood Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities. It is developing its lead product candidate, Oxbryta (voxelotor) tablets, an oral, once-daily therapy for sickle cell disease (SCD). The company is evaluating Oxbryta that has completed Phase III clinical trial in adult and adolescent patients with SCD. It is also evaluating the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase IIa clinical trial of adolescent and pediatric patients with SCD. The company has a license and collaboration agreement with Syros Pharmaceuticals, Inc. to discover, develop, and commercialize therapies for SCD) and beta thalassemia. Global Blood Therapeutics, Inc. was founded in 2011 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Svoronos DawnDirectorJun 19Sale63.942,544162,6632,256Jun 19 09:31 PM
Farrow Jeffrey SChief Financial OfficerJun 09Sale67.0015,2081,018,93618,256Jun 11 04:06 PM
Calhoun Lesley AnnSee RemarksMay 26Option Exercise29.752,70080,3252,854May 28 04:05 PM
Calhoun Lesley AnnSee RemarksMay 26Sale70.102,700189,270154May 28 04:05 PM
Calhoun Lesley AnnSee RemarksMay 18Option Exercise22.0023,330513,26023,484May 20 04:07 PM
Calhoun Lesley AnnSee RemarksMay 18Sale74.6723,3301,742,051154May 20 04:07 PM
PERRY MARK LDirectorMay 12Option Exercise22.0453,6001,181,50080,028May 13 06:07 PM
Calhoun Lesley AnnSee RemarksMay 12Sale78.382,992234,512154May 13 06:08 PM
PERRY MARK LDirectorMay 12Sale78.1053,6004,186,06126,428May 13 06:07 PM
Calhoun Lesley AnnSee RemarksMay 11Sale77.0538129,3563,146May 13 06:08 PM
LOVE TED WSee RemarksApr 28Sale80.0040,0003,200,1601,034,633Apr 29 04:17 PM
LOVE TED WSee RemarksApr 27Sale80.872,817227,8141,074,633Apr 29 04:17 PM
SUVARI TRICIA BORGAChief Legal OfficerApr 20Sale75.004,080306,0007,441Apr 22 04:05 PM
Brown Willie L. Jr.DirectorMar 13Buy52.3710,000523,70031,428Mar 17 05:53 PM
Lehrer-Graiwer JoshuaChief Medical OfficerMar 09Option Exercise19.8993818,6573,533Mar 09 07:37 PM
Lehrer-Graiwer JoshuaChief Medical OfficerMar 09Sale59.9093856,1862,595Mar 09 07:37 PM
Lehrer-Graiwer JoshuaChief Medical OfficerMar 05Sale65.301,13874,3112,595Mar 09 07:37 PM
Lehrer-Graiwer JoshuaChief Medical OfficerFeb 18Option Exercise26.901,31335,3203,908Feb 20 06:25 PM
Lehrer-Graiwer JoshuaChief Medical OfficerFeb 18Sale69.711,31391,5292,595Feb 20 06:25 PM
LOVE TED WSee RemarksFeb 18Sale70.544,007282,6601,077,450Feb 20 06:20 PM
Lehrer-Graiwer JoshuaChief Medical OfficerFeb 10Option Exercise12.956258,0943,220Feb 10 07:49 PM
Lehrer-Graiwer JoshuaChief Medical OfficerFeb 10Sale70.4862544,0502,595Feb 10 07:49 PM
Lehrer-Graiwer JoshuaChief Medical OfficerFeb 06Sale72.403,937285,0392,595Feb 10 07:49 PM
Lehrer-Graiwer JoshuaChief Medical OfficerFeb 03Option Exercise53.253,845204,7448,720Feb 04 08:47 PM
Lehrer-Graiwer JoshuaChief Medical OfficerFeb 03Sale63.753,845245,1336,532Feb 04 08:47 PM
SUVARI TRICIA BORGAChief Legal OfficerFeb 03Sale62.811,30882,15511,521Feb 04 08:44 PM
Lehrer-Graiwer JoshuaChief Medical OfficerJan 27Option Exercise27.9078121,7902,797Jan 29 04:47 PM
Lehrer-Graiwer JoshuaChief Medical OfficerJan 27Sale71.1578155,5682,016Jan 29 04:47 PM
LOVE TED WSee RemarksJan 22Sale81.7340,0003,269,0471,061,984Jan 23 04:05 PM
LOVE TED WSee RemarksJan 21Sale82.2040,0003,288,1011,101,984Jan 23 04:05 PM
SUVARI TRICIA BORGAChief Legal OfficerJan 02Sale79.781,308104,3528,348Jan 03 07:17 PM
Pizzo Philip A.DirectorDec 11Option Exercise23.6530,000709,50030,000Dec 13 05:46 PM
Pizzo Philip A.DirectorDec 11Sale76.5730,0002,297,2280Dec 13 05:46 PM
Lehrer-Graiwer JoshuaChief Medical OfficerDec 09Option Exercise19.8993718,637937Dec 11 05:27 PM
Lehrer-Graiwer JoshuaChief Medical OfficerDec 09Sale78.5093773,5550Dec 11 05:27 PM
LOVE TED WSee Remarks.Dec 06Sale77.1040,0003,083,9341,097,867Dec 09 06:25 PM
LOVE TED WSee Remarks.Dec 05Sale74.9740,0002,998,8721,137,867Dec 09 06:25 PM
SUVARI TRICIA BORGAChief Legal OfficerDec 02Sale66.743,434229,1856,752Dec 03 07:18 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 26Option Exercise59.6011,593690,94311,593Nov 27 04:47 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 26Sale67.1911,593778,9340Nov 27 04:47 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 25Option Exercise25.6410,930280,2394,594Nov 27 04:47 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 25Sale60.0010,930655,8000Nov 27 04:47 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 19Option Exercise48.446,562317,8636,562Nov 20 06:11 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 19Sale55.006,562360,9100Nov 20 06:11 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 18Option Exercise26.9065617,646656Nov 20 06:11 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 18Sale50.6365633,2130Nov 20 06:11 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 15Option Exercise25.749,948256,0749,948Nov 18 05:43 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 15Sale50.009,948497,4470Nov 18 05:43 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 14Option Exercise20.003296,580329Nov 18 05:43 PM
Lehrer-Graiwer JoshuaChief Medical OfficerNov 14Sale50.0132916,4550Nov 18 05:43 PM
SUVARI TRICIA BORGAChief Legal OfficerNov 01Sale48.453,327161,19210,186Nov 05 04:05 PM
PATRICK DEVAL LDirectorOct 08Option Exercise3.405,35718,2145,357Oct 10 04:52 PM
PATRICK DEVAL LDirectorOct 08Sale45.055,357241,3330Oct 10 04:52 PM
SUVARI TRICIA BORGAChief Legal OfficerOct 01Sale48.703,249158,22613,513Oct 02 07:22 PM
Calhoun Lesley AnnSee RemarksSep 11Sale54.362,765150,296887Sep 13 04:45 PM